1 . Crohn's & Colitis Foundation of America. "The Facts About Inflammatory Bowel Diseases" . Inflammatory Bowel Diseases. 2014;2.

2 . Abraham C, Cho JH. "Inflammatory bowel disease. Mechanism of disease - review article" . NEJM. 2009; 361:2066-2078.

3 . GBD 2017 Inflammatory Bowel Disease Collaborators. "The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017" . Lancet Gastroenterol Hepatol. 2020; 5:17-30.

4 . Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al.. "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" . Lancet. 2017; 390:2769-2778.

5 . Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. "Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years — United States, 2015" . MMWR. 2016; 65;1166-1169

6 . Abdulla M, Al Saeed M, Fardan RH, Alalwan HF, Ali Almosawi ZS, Almahroos AF, et al.. "Inflammatory bowel disease in Bahrain: single-center experience" . Clin Exp Gastroenterol. 2017; 10:133-145.

7 . Butt MT, Bener A, Al-Kaabi S, Yakoub R. "Clinical characteristics of Crohn s disease in Qatar" . Saudi Med J. 2005; 26:1796-9.

8 . Khawaja AQ, Sawan AS. "Inflammatory bowel disease in the Western Saudi Arabia" . Saudi Med J. 2009; 30:537-40.

9 . Fadda MA, Peedikayil MC, Kagevi I, Kahtani KA, Ben AA, Al HI, et al.. "Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients" . Ann Saudi Med. 2012; 32:276-82.

10 . Mak WY, Zhao M, Ng SC, Burisch J. "The epidemiology of inflammatory bowel disease: East meets west" . J Gastroenterol Hepatol. 2020; 35:380-389.

11 . Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. "Inflammatory bowel disease: estimates from the global burden of disease 2017 study" . Aliment Pharmacol Ther. 2020; 51:261-270.

12 . Ng SC. "Emerging Trends of Inflammatory Bowel Disease in Asia" . Gastroenterol Hepatol (NY). 2016; 12:193-6.

13 . Brant SR, Nguyen GC. "Is there a gender difference in the prevalence of Crohn's disease or ulcerative colitis?" Inflammatory bowel diseases. 2008;14.

14 . Rustgi SD, Kayal M, Shah SC. "Sex-based differences in inflammatory bowel diseases: a review" . Therap Adv Gastroenterol. 2020; 13:1756284820915043.

15 . M Alqarni SS. "A Review of Prevalence of Obesity in Saudi Arabia" . J Obes Eat Disord. 2016;02.

16 . Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. "Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes" . Nat Rev Gastroenterol Hepatol. 2017; 14:110-121.

17 . Mulgund A, Stein D. "Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year" . Dig Dis Sci. 2020; 65:3420-3421.

18 . Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, et al.. (2019). "Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study" . PLoS ONE, 14(4).

19 . Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. "The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis" . Am J Gastroenterol. 2007; 102:1042-9.

20 . Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, et al.. "Hepatic and extrahepatic malignancies in primary sclerosing cholangitis" . J Hepatol. 2002; 36:321-7.

21 . Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. "Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis" . Dig Dis Sci. 2007; 52:3123-35.

22 . Talwalkar JA, Lindor KD. "Primary sclerosing cholangitis" . Inflamm Bowel Dis. 2005; 11:62-72.

23 . Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al.. "PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis" . Gut. 2005; 54:91-6.

24 . Fuller-Thomson E, Sulman J. "Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys" . Inflamm Bowel Dis. 2006; 12:697-707.

25 . Iglesias M, Barreiro de Acosta M, Vázquez I, Figueiras A, Nieto L, Lorenzo A, et al.. "psychological impact of Crohn's disease on patients in remission: anxiety and depression risks" . Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2009; 101; 249-57.

26 . Taft TH, Keefer L. "A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease" . Clin Exp Gastroenterol. 2016; 9:49-58.

27 . Taft TH, Bedell A, Naftaly J, Keefer L. "Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort" . Neurogastroenterol Motil. 2017; 29:10.

28 . Nicolaides S, Vasudevan A, Long T, van Langenberg D. "The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease" . Intest Res. 2021; 19:158-170.

29 . O’Connor M. Ulcerative Colitis-Epidemiology, Pathogenesis and Complication. 14th Ed. Ireland, South Infirmary Victoria University Hospital; 2011.

30 . Molander P, Kemppainen H, Ilus T, & Sipponen T. (2020). "Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases" . Scandinavian Journal of Gastroenterology, 55(1).

31 . Mao R, Hu PJ. "The Future of IBD Therapy: Where Are We and Where Should We Go Next?" Dig Dis. 2016; 34:175-9.